{"id":987507945,"date":"2025-10-28T13:41:20","date_gmt":"2025-10-28T13:41:20","guid":{"rendered":"https:\/\/hollandcapital.nl\/?p=987507945"},"modified":"2025-10-28T13:42:03","modified_gmt":"2025-10-28T13:42:03","slug":"semalytix-secures-e5-7-million-to-scale-its-agentic-ai-platform-embedding-real-world-patient-insights-directly-into-pharma-workflows","status":"publish","type":"post","link":"https:\/\/hollandcapital.nl\/en\/semalytix-secures-e5-7-million-to-scale-its-agentic-ai-platform-embedding-real-world-patient-insights-directly-into-pharma-workflows\/","title":{"rendered":"Semalytix Secures \u20ac5.7 Million to Scale its Agentic AI Platform"},"content":{"rendered":"\n[et_pb_section fb_built=”1″ _builder_version=”4.24.2″ _module_preset=”default” background_color=”#213564″ background_enable_image=”off” background_position=”top_center” background_vertical_offset=”38%” background_blend=”soft-light” height=”30vh” custom_padding=”0vh||8vh||false|false” global_colors_info=”{}”][\/et_pb_section][et_pb_section fb_built=”1″ _builder_version=”4.18.1″ _module_preset=”default” custom_padding=”100px||100px||true|” global_colors_info=”{}”][et_pb_row _builder_version=”4.20.4″ _module_preset=”default” custom_margin=”|auto|15px|auto||” custom_padding=”0px|||||” locked=”off” global_colors_info=”{}”][et_pb_column type=”4_4″ _builder_version=”4.20.4″ _module_preset=”default” global_colors_info=”{}”][et_pb_text _builder_version=”4.27.4″ _module_preset=”default” text_font=”|800|||||||” text_text_color=”#243B66″ text_font_size=”35px” text_line_height=”1.2em” custom_margin=”||12px|||” hover_enabled=”0″ global_colors_info=”{}” sticky_enabled=”0″]

Semalytix Secures \u20ac5.7 Million to scale its agentic AI platform, embedding real-world patient insights directly into pharma workflows<\/strong><\/p>[\/et_pb_text][et_pb_divider show_divider=”off” _builder_version=”4.27.4″ _module_preset=”default” width=”15%” custom_margin=”10px||||false|false” border_width_top=”3px” border_color_top=”#B68013″ border_color_bottom=”#B68013″ global_colors_info=”{}”][\/et_pb_divider][\/et_pb_column][\/et_pb_row][et_pb_row _builder_version=”4.18.1″ _module_preset=”default” custom_margin=”-29px|auto||auto||” custom_padding=”33px||27px|||” global_colors_info=”{}”][et_pb_column type=”4_4″ _builder_version=”4.18.1″ _module_preset=”default” global_colors_info=”{}”][et_pb_text _builder_version=”4.27.4″ _module_preset=”default” header_font=”|800|||||||” header_text_color=”#283583″ header_2_font=”|800|||||||” header_2_text_color=”#283583″ header_2_font_size=”20px” hover_enabled=”0″ global_colors_info=”{}” sticky_enabled=”0″ custom_padding=”0px|||||”]

\n
\n
\n

Bielefeld (Germany), Amsterdam \u2013\u00a0October 28<\/span>th, 2025<\/span>\u00a0\u2013 Semalytix, a leader in Agentic AI for pharmaceutical patient intelligence,\u00a0today\u00a0announced the successful closing of its \u20ac5.7 million growth round. The round was led by Holland Capital, a prominent Dutch venture capital firm focusing on the Technology and Healthcare sectors, with participation from existing investors.<\/strong><\/p>\n

Semalytix<\/a> <\/span>addresses a critical need in the pharmaceutical sector. The Life Science industry currently generates approximately 30% of the world’s data, and the ability to transform vast amounts of unstructured patient data from public (social) sources into real-time, actionable insights is paramount. Semalytix’s advanced AI-powered analytics technology, PatientGPT, is designed to meet this challenge directly. Evolving rapidly, the team has expanded its AI data foundation to include 33 million medical publications and 100,000+ clinical trial outcomes, and has forged a new generation of Agentic AI models tailored to support specific Pharma roles with crucial patient experience outcomes at every stage of modern drug development. The company has already demonstrated strong commercial traction with several top-20 pharmaceutical companies.<\/p>\n

The new funding will be instrumental in accelerating Semalytix’s growth trajectory. Proceeds will be used to further enhance its AI platform’s capabilities, expand its international footprint, particularly in Europe and the USA, strengthen its management and commercial teams, and scale its operational capacity to meet growing customer demand.<\/p>\n

“This growth funding is a significant milestone for Semalytix and validates our vision to revolutionise how patient insights are generated and utilised in the pharmaceutical industry,”<\/em> said Janik Jaskolski<\/a><\/span>, MSc, Co-Founder and CEO of Semalytix. “We are thrilled to welcome Holland Capital as our new partner. Their deep expertise in scaling technology and healthcare companies, demonstrated by their proven track record, including the recent successful exit of HealthConnected to Visma, combined with their strong network, will be invaluable as we enter our next phase of accelerated growth. We are also grateful for the continued trust and support from our existing investors.”<\/em><\/p>\n

Jan-Frens van Giessel<\/a><\/span>, Partner Healthcare at Holland Capital, commented: “Semalytix addresses a clear and growing need in the Pharma market with its unique AI technology capable of delivering scalable, real-time patient insights. We are impressed by the company’s strong commercial traction, highly defensible technology, and the ambitious vision of the founding team. Holland Capital is excited to partner with Semalytix and leverage our experience to support their journey in becoming a global leader in AI-powered patient intelligence.”<\/em><\/p>\n

About Semalytix GmbH<\/span><\/p>\n

Based in Bielefeld, Germany, Semalytix GmbH provides an\u00a0<\/strong>Agentic AI platform\u00a0for the pharmaceutical industry. Its PatientGPT-powered Atlas platform enables Pharma teams to compliantly access the global patient voice and, increasingly, to\u00a0build, deploy, and own a library of custom AI models. This “Agent-as-a-Service” model allows companies to embed patient intelligence directly into their workflows, a critical capability given that 75-85% of pharmaceutical workflows are estimated to contain tasks that can be automated or augmented by AI agents. This model allows companies to build\u00a0compounding intellectual property, moving beyond disposable research to create durable strategic assets.<\/p>\n

About Holland Capital<\/h2>\n

<\/p>\n

Holland <\/span>Capital<\/span> has been <\/span>responsibly<\/span> <\/span>and<\/span> <\/span>successfully<\/span> <\/span>\u202f<\/span>investing<\/span>\u202fin <\/span>promising<\/span> Dutch <\/span>and<\/span> <\/span>German<\/span> <\/span>SMEs<\/span> <\/span>with<\/span> <\/span>growth<\/span> <\/span>ambitions<\/span> <\/span>for<\/span> over 40 <\/span>years<\/span>. The\u202fteam\u202f<\/span>understands<\/span> <\/span>entrepreneurship<\/span> <\/span>and<\/span> <\/span>fosters<\/span> <\/span>an<\/span> open, <\/span>sustainable<\/span>, <\/span>and<\/span> professional <\/span>relationship<\/span> <\/span>with<\/span> <\/span>the<\/span> management teams of <\/span>the<\/span> <\/span>invested<\/span> companies, <\/span>aiming<\/span> <\/span>for<\/span> <\/span>mutual<\/span> <\/span>growth<\/span>. <\/span>With<\/span> offices in Amsterdam <\/span>and<\/span> D\u00fcsseldorf, Holland <\/span>Capital<\/span> <\/span>focuses<\/span> on Healthcare <\/span>and<\/span> Technology sector.<\/span><\/p>\n<\/div>\n<\/div>\n<\/div>[\/et_pb_text][\/et_pb_column][\/et_pb_row][\/et_pb_section][et_pb_section fb_built=”1″ _builder_version=”4.18.1″ _module_preset=”default” background_color=”#EFEFEF” background_image=”https:\/\/hollandcapital.nl\/wp-content\/uploads\/2022\/11\/Molen_wit.png” background_blend=”soft-light” custom_padding=”100px||50px||false|” box_shadow_style=”preset6″ global_colors_info=”{}”][et_pb_row _builder_version=”4.18.1″ _module_preset=”default” global_colors_info=”{}”][et_pb_column type=”4_4″ _builder_version=”4.18.1″ _module_preset=”default” global_colors_info=”{}”][et_pb_blog fullwidth=”off” posts_number=”6″ include_categories=”31,97″ show_author=”off” show_categories=”off” show_excerpt=”off” _builder_version=”4.20.4″ _module_preset=”default” header_font=”|800|||||||” header_text_color=”#252E82″ body_text_color=”#000000″ meta_text_color=”#B68013″ pagination_text_color=”#B68013″ custom_css_title=”height: 100px;” border_radii=”on|5px|5px|5px|5px” border_width_all=”0px” box_shadow_style=”preset1″ global_colors_info=”{}” header_text_color__hover_enabled=”on|hover” header_text_color__hover=”#252E82″][\/et_pb_blog][\/et_pb_column][\/et_pb_row][\/et_pb_section][et_pb_section fb_built=”1″ _builder_version=”4.24.2″ _module_preset=”default” background_color=”#213564″ custom_margin=”||||false|false” custom_padding=”60px||29px||false|false” saved_tabs=”all” global_colors_info=”{}”][et_pb_row column_structure=”1_5,1_5,1_5,1_5,1_5″ make_equal=”on” _builder_version=”4.18.1″ _module_preset=”default” custom_margin=”|auto|6px|auto||” custom_padding=”0px||0px|||” global_colors_info=”{}”][et_pb_column type=”1_5″ _builder_version=”4.18.1″ _module_preset=”default” global_colors_info=”{}”][et_pb_image src=”https:\/\/hollandcapital.nl\/wp-content\/uploads\/2022\/11\/Holland-capital-logo-wit.png” title_text=”Holland capital logo-wit” _builder_version=”4.18.1″ _module_preset=”default” transform_translate_linked=”off” width=”91%” custom_margin=”||||false|false” global_colors_info=”{}”][\/et_pb_image][\/et_pb_column][et_pb_column type=”1_5″ _builder_version=”4.18.1″ _module_preset=”default” global_colors_info=”{}”][\/et_pb_column][et_pb_column type=”1_5″ _builder_version=”4.18.1″ _module_preset=”default” global_colors_info=”{}”][\/et_pb_column][et_pb_column type=”1_5″ _builder_version=”4.18.1″ _module_preset=”default” custom_css_main_element=”margin:auto;” global_colors_info=”{}”][\/et_pb_column][et_pb_column type=”1_5″ _builder_version=”4.18.1″ _module_preset=”default” custom_css_main_element=”margin:auto;” global_colors_info=”{}”][et_pb_social_media_follow use_icon_font_size=”on” _builder_version=”4.18.1″ _module_preset=”default” custom_button=”on” button_text_size=”16px” button_text_color=”#283583″ button_bg_color=”#FFFFFF” button_border_color=”#FFFFFF” button_font=”|600|||||||” button_custom_margin=”||||false|false” button_custom_padding=”||||false|false” text_orientation=”left” background_layout=”dark” custom_margin=”||7px||false|false” global_colors_info=”{}”][et_pb_social_media_follow_network social_network=”linkedin” url=”https:\/\/www.linkedin.com\/company\/hollandcapital\/” icon_color=”#283583″ _builder_version=”4.18.1″ _module_preset=”default” background_color=”#FFFFFF” background_enable_color=”on” global_colors_info=”{}” follow_button=”off” url_new_window=”on”]LinkedIn[\/et_pb_social_media_follow_network][\/et_pb_social_media_follow][\/et_pb_column][\/et_pb_row][et_pb_row column_structure=”1_5,1_5,1_5,1_5,1_5″ _builder_version=”4.18.1″ _module_preset=”default” custom_margin=”|auto|6px|auto||” custom_padding=”22px||6px|||” global_colors_info=”{}”][et_pb_column type=”1_5″ _builder_version=”4.18.1″ _module_preset=”default” global_colors_info=”{}”][et_pb_text _builder_version=”4.18.1″ _module_preset=”default” text_font=”Lato||||||||” text_text_color=”#FFFFFF” text_font_size=”16px” global_colors_info=”{}”]

Amsterdam<\/strong><\/span>
Krijn Taconiskade 426
1087 HW Amsterdam
+31 (0) 20 3119411<\/p>\n

 <\/p>[\/et_pb_text][\/et_pb_column][et_pb_column type=”1_5″ _builder_version=”4.18.1″ _module_preset=”default” global_colors_info=”{}”][et_pb_text _builder_version=”4.18.1″ _module_preset=”default” text_font=”Lato||||||||” text_text_color=”#FFFFFF” text_font_size=”16px” global_colors_info=”{}”]

D\u00fcsseldorf<\/strong><\/span>
K\u00f6nigsallee 42
40212 D\u00fcsseldorf
+49 (0) 211 96290120<\/p>[\/et_pb_text][\/et_pb_column][et_pb_column type=”1_5″ _builder_version=”4.18.1″ _module_preset=”default” global_colors_info=”{}”][et_pb_text _builder_version=”4.18.1″ _module_preset=”default” text_font=”Lato||||||||” text_text_color=”#FFFFFF” text_font_size=”16px” global_colors_info=”{}”]

Contact<\/strong><\/span>
info@hollandcapital.nl<\/p>[\/et_pb_text][\/et_pb_column][et_pb_column type=”1_5″ _builder_version=”4.18.1″ _module_preset=”default” global_colors_info=”{}”][\/et_pb_column][et_pb_column type=”1_5″ _builder_version=”4.18.1″ _module_preset=”default” global_colors_info=”{}”][et_pb_text _builder_version=”4.18.1″ _module_preset=”default” text_font=”Lato||||||||solid” text_text_color=”#FFFFFF” text_font_size=”16px” link_text_color=”#FFFFFF” custom_margin=”1px||||false|false” global_colors_info=”{}” link_text_color__hover_enabled=”on|desktop” link_text_color__hover=”#B68013″]

\n

Privacy statement<\/span><\/a><\/p>[\/et_pb_text][\/et_pb_column][\/et_pb_row][\/et_pb_section]\n","protected":false},"excerpt":{"rendered":"

Semalytix, a leader in Agentic AI for pharmaceutical patient intelligence, today announced the successful closing of its \u20ac5.7 million growth round. <\/p>\n","protected":false},"author":4,"featured_media":987507937,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_et_pb_use_builder":"on","_et_pb_old_content":"","_et_gb_content_width":"2880","footnotes":"","_links_to":"","_links_to_target":""},"categories":[97],"tags":[172,174,175,176],"class_list":["post-987507945","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-news-engels","tag-growth-en","tag-investeren-en","tag-technology-en-2","tag-healthcare-en"],"yoast_head":"\nSemalytix Secures \u20ac5.7 Million to Scale its Agentic AI Platform - Holland Capital<\/title>\n<meta name=\"description\" content=\"Semalytix, a leader in Agentic AI for pharmaceutical patient intelligence, today announced the successful closing of its \u20ac5.7 million growth round. .\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/hollandcapital.nl\/en\/semalytix-secures-e5-7-million-to-scale-its-agentic-ai-platform-embedding-real-world-patient-insights-directly-into-pharma-workflows\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Semalytix Secures \u20ac5.7 Million to Scale its Agentic AI Platform\" \/>\n<meta property=\"og:description\" content=\"Semalytix, a leader in Agentic AI for pharmaceutical patient intelligence, today announced the successful closing of its \u20ac5.7 million growth round. .\" \/>\n<meta property=\"og:url\" content=\"https:\/\/hollandcapital.nl\/en\/semalytix-secures-e5-7-million-to-scale-its-agentic-ai-platform-embedding-real-world-patient-insights-directly-into-pharma-workflows\/\" \/>\n<meta property=\"og:site_name\" content=\"Holland Capital\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.linkedin.com\/company\/hollandcapital\/\" \/>\n<meta property=\"article:published_time\" content=\"2025-10-28T13:41:20+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2025-10-28T13:42:03+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/hollandcapital.nl\/wp-content\/uploads\/2025\/10\/Semalytix-2.png\" \/>\n\t<meta property=\"og:image:width\" content=\"320\" \/>\n\t<meta property=\"og:image:height\" content=\"200\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"author\" content=\"Grytsje\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Grytsje\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"6 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/hollandcapital.nl\\\/en\\\/semalytix-secures-e5-7-million-to-scale-its-agentic-ai-platform-embedding-real-world-patient-insights-directly-into-pharma-workflows\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/hollandcapital.nl\\\/en\\\/semalytix-secures-e5-7-million-to-scale-its-agentic-ai-platform-embedding-real-world-patient-insights-directly-into-pharma-workflows\\\/\"},\"author\":{\"name\":\"Grytsje\",\"@id\":\"https:\\\/\\\/hollandcapital.nl\\\/#\\\/schema\\\/person\\\/47531bfba3e92fb43b39366649af58c9\"},\"headline\":\"Semalytix Secures \u20ac5.7 Million to Scale its Agentic AI Platform\",\"datePublished\":\"2025-10-28T13:41:20+00:00\",\"dateModified\":\"2025-10-28T13:42:03+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/hollandcapital.nl\\\/en\\\/semalytix-secures-e5-7-million-to-scale-its-agentic-ai-platform-embedding-real-world-patient-insights-directly-into-pharma-workflows\\\/\"},\"wordCount\":1507,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\\\/\\\/hollandcapital.nl\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/hollandcapital.nl\\\/en\\\/semalytix-secures-e5-7-million-to-scale-its-agentic-ai-platform-embedding-real-world-patient-insights-directly-into-pharma-workflows\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/hollandcapital.nl\\\/wp-content\\\/uploads\\\/2025\\\/10\\\/Semalytix-2.png\",\"keywords\":[\"Growth\",\"investeren\",\"Technology\",\"Healthcare\"],\"articleSection\":[\"News Engels\"],\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\\\/\\\/hollandcapital.nl\\\/en\\\/semalytix-secures-e5-7-million-to-scale-its-agentic-ai-platform-embedding-real-world-patient-insights-directly-into-pharma-workflows\\\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/hollandcapital.nl\\\/en\\\/semalytix-secures-e5-7-million-to-scale-its-agentic-ai-platform-embedding-real-world-patient-insights-directly-into-pharma-workflows\\\/\",\"url\":\"https:\\\/\\\/hollandcapital.nl\\\/en\\\/semalytix-secures-e5-7-million-to-scale-its-agentic-ai-platform-embedding-real-world-patient-insights-directly-into-pharma-workflows\\\/\",\"name\":\"Semalytix Secures \u20ac5.7 Million to Scale its Agentic AI Platform - Holland Capital\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/hollandcapital.nl\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/hollandcapital.nl\\\/en\\\/semalytix-secures-e5-7-million-to-scale-its-agentic-ai-platform-embedding-real-world-patient-insights-directly-into-pharma-workflows\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/hollandcapital.nl\\\/en\\\/semalytix-secures-e5-7-million-to-scale-its-agentic-ai-platform-embedding-real-world-patient-insights-directly-into-pharma-workflows\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/hollandcapital.nl\\\/wp-content\\\/uploads\\\/2025\\\/10\\\/Semalytix-2.png\",\"datePublished\":\"2025-10-28T13:41:20+00:00\",\"dateModified\":\"2025-10-28T13:42:03+00:00\",\"description\":\"Semalytix, a leader in Agentic AI for pharmaceutical patient intelligence, today announced the successful closing of its \u20ac5.7 million growth round. .\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/hollandcapital.nl\\\/en\\\/semalytix-secures-e5-7-million-to-scale-its-agentic-ai-platform-embedding-real-world-patient-insights-directly-into-pharma-workflows\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/hollandcapital.nl\\\/en\\\/semalytix-secures-e5-7-million-to-scale-its-agentic-ai-platform-embedding-real-world-patient-insights-directly-into-pharma-workflows\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/hollandcapital.nl\\\/en\\\/semalytix-secures-e5-7-million-to-scale-its-agentic-ai-platform-embedding-real-world-patient-insights-directly-into-pharma-workflows\\\/#primaryimage\",\"url\":\"https:\\\/\\\/hollandcapital.nl\\\/wp-content\\\/uploads\\\/2025\\\/10\\\/Semalytix-2.png\",\"contentUrl\":\"https:\\\/\\\/hollandcapital.nl\\\/wp-content\\\/uploads\\\/2025\\\/10\\\/Semalytix-2.png\",\"width\":320,\"height\":200},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/hollandcapital.nl\\\/en\\\/semalytix-secures-e5-7-million-to-scale-its-agentic-ai-platform-embedding-real-world-patient-insights-directly-into-pharma-workflows\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/hollandcapital.nl\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Semalytix Secures \u20ac5.7 Million to Scale its Agentic AI Platform\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/hollandcapital.nl\\\/#website\",\"url\":\"https:\\\/\\\/hollandcapital.nl\\\/\",\"name\":\"Holland Capital\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/hollandcapital.nl\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/hollandcapital.nl\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/hollandcapital.nl\\\/#organization\",\"name\":\"Holland Capital Management BV\",\"url\":\"https:\\\/\\\/hollandcapital.nl\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/hollandcapital.nl\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/hollandcapital.nl\\\/wp-content\\\/uploads\\\/2023\\\/06\\\/HC_logo_handtekening.png\",\"contentUrl\":\"https:\\\/\\\/hollandcapital.nl\\\/wp-content\\\/uploads\\\/2023\\\/06\\\/HC_logo_handtekening.png\",\"width\":186,\"height\":65,\"caption\":\"Holland Capital Management BV\"},\"image\":{\"@id\":\"https:\\\/\\\/hollandcapital.nl\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/www.linkedin.com\\\/company\\\/hollandcapital\\\/\"]},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/hollandcapital.nl\\\/#\\\/schema\\\/person\\\/47531bfba3e92fb43b39366649af58c9\",\"name\":\"Grytsje\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/287ef07ad6e09cb3368ae7d01a80dfd73cb7a9bb6d5a8f35a2dd4f0c09b95f9a?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/287ef07ad6e09cb3368ae7d01a80dfd73cb7a9bb6d5a8f35a2dd4f0c09b95f9a?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/287ef07ad6e09cb3368ae7d01a80dfd73cb7a9bb6d5a8f35a2dd4f0c09b95f9a?s=96&d=mm&r=g\",\"caption\":\"Grytsje\"},\"url\":\"https:\\\/\\\/hollandcapital.nl\\\/en\\\/author\\\/grytsje\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"Semalytix Secures \u20ac5.7 Million to Scale its Agentic AI Platform - Holland Capital","description":"Semalytix, a leader in Agentic AI for pharmaceutical patient intelligence, today announced the successful closing of its \u20ac5.7 million growth round. .","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/hollandcapital.nl\/en\/semalytix-secures-e5-7-million-to-scale-its-agentic-ai-platform-embedding-real-world-patient-insights-directly-into-pharma-workflows\/","og_locale":"en_US","og_type":"article","og_title":"Semalytix Secures \u20ac5.7 Million to Scale its Agentic AI Platform","og_description":"Semalytix, a leader in Agentic AI for pharmaceutical patient intelligence, today announced the successful closing of its \u20ac5.7 million growth round. .","og_url":"https:\/\/hollandcapital.nl\/en\/semalytix-secures-e5-7-million-to-scale-its-agentic-ai-platform-embedding-real-world-patient-insights-directly-into-pharma-workflows\/","og_site_name":"Holland Capital","article_publisher":"https:\/\/www.linkedin.com\/company\/hollandcapital\/","article_published_time":"2025-10-28T13:41:20+00:00","article_modified_time":"2025-10-28T13:42:03+00:00","og_image":[{"width":320,"height":200,"url":"https:\/\/hollandcapital.nl\/wp-content\/uploads\/2025\/10\/Semalytix-2.png","type":"image\/png"}],"author":"Grytsje","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Grytsje","Est. reading time":"6 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/hollandcapital.nl\/en\/semalytix-secures-e5-7-million-to-scale-its-agentic-ai-platform-embedding-real-world-patient-insights-directly-into-pharma-workflows\/#article","isPartOf":{"@id":"https:\/\/hollandcapital.nl\/en\/semalytix-secures-e5-7-million-to-scale-its-agentic-ai-platform-embedding-real-world-patient-insights-directly-into-pharma-workflows\/"},"author":{"name":"Grytsje","@id":"https:\/\/hollandcapital.nl\/#\/schema\/person\/47531bfba3e92fb43b39366649af58c9"},"headline":"Semalytix Secures \u20ac5.7 Million to Scale its Agentic AI Platform","datePublished":"2025-10-28T13:41:20+00:00","dateModified":"2025-10-28T13:42:03+00:00","mainEntityOfPage":{"@id":"https:\/\/hollandcapital.nl\/en\/semalytix-secures-e5-7-million-to-scale-its-agentic-ai-platform-embedding-real-world-patient-insights-directly-into-pharma-workflows\/"},"wordCount":1507,"commentCount":0,"publisher":{"@id":"https:\/\/hollandcapital.nl\/#organization"},"image":{"@id":"https:\/\/hollandcapital.nl\/en\/semalytix-secures-e5-7-million-to-scale-its-agentic-ai-platform-embedding-real-world-patient-insights-directly-into-pharma-workflows\/#primaryimage"},"thumbnailUrl":"https:\/\/hollandcapital.nl\/wp-content\/uploads\/2025\/10\/Semalytix-2.png","keywords":["Growth","investeren","Technology","Healthcare"],"articleSection":["News Engels"],"inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/hollandcapital.nl\/en\/semalytix-secures-e5-7-million-to-scale-its-agentic-ai-platform-embedding-real-world-patient-insights-directly-into-pharma-workflows\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/hollandcapital.nl\/en\/semalytix-secures-e5-7-million-to-scale-its-agentic-ai-platform-embedding-real-world-patient-insights-directly-into-pharma-workflows\/","url":"https:\/\/hollandcapital.nl\/en\/semalytix-secures-e5-7-million-to-scale-its-agentic-ai-platform-embedding-real-world-patient-insights-directly-into-pharma-workflows\/","name":"Semalytix Secures \u20ac5.7 Million to Scale its Agentic AI Platform - Holland Capital","isPartOf":{"@id":"https:\/\/hollandcapital.nl\/#website"},"primaryImageOfPage":{"@id":"https:\/\/hollandcapital.nl\/en\/semalytix-secures-e5-7-million-to-scale-its-agentic-ai-platform-embedding-real-world-patient-insights-directly-into-pharma-workflows\/#primaryimage"},"image":{"@id":"https:\/\/hollandcapital.nl\/en\/semalytix-secures-e5-7-million-to-scale-its-agentic-ai-platform-embedding-real-world-patient-insights-directly-into-pharma-workflows\/#primaryimage"},"thumbnailUrl":"https:\/\/hollandcapital.nl\/wp-content\/uploads\/2025\/10\/Semalytix-2.png","datePublished":"2025-10-28T13:41:20+00:00","dateModified":"2025-10-28T13:42:03+00:00","description":"Semalytix, a leader in Agentic AI for pharmaceutical patient intelligence, today announced the successful closing of its \u20ac5.7 million growth round. .","breadcrumb":{"@id":"https:\/\/hollandcapital.nl\/en\/semalytix-secures-e5-7-million-to-scale-its-agentic-ai-platform-embedding-real-world-patient-insights-directly-into-pharma-workflows\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/hollandcapital.nl\/en\/semalytix-secures-e5-7-million-to-scale-its-agentic-ai-platform-embedding-real-world-patient-insights-directly-into-pharma-workflows\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/hollandcapital.nl\/en\/semalytix-secures-e5-7-million-to-scale-its-agentic-ai-platform-embedding-real-world-patient-insights-directly-into-pharma-workflows\/#primaryimage","url":"https:\/\/hollandcapital.nl\/wp-content\/uploads\/2025\/10\/Semalytix-2.png","contentUrl":"https:\/\/hollandcapital.nl\/wp-content\/uploads\/2025\/10\/Semalytix-2.png","width":320,"height":200},{"@type":"BreadcrumbList","@id":"https:\/\/hollandcapital.nl\/en\/semalytix-secures-e5-7-million-to-scale-its-agentic-ai-platform-embedding-real-world-patient-insights-directly-into-pharma-workflows\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/hollandcapital.nl\/"},{"@type":"ListItem","position":2,"name":"Semalytix Secures \u20ac5.7 Million to Scale its Agentic AI Platform"}]},{"@type":"WebSite","@id":"https:\/\/hollandcapital.nl\/#website","url":"https:\/\/hollandcapital.nl\/","name":"Holland Capital","description":"","publisher":{"@id":"https:\/\/hollandcapital.nl\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/hollandcapital.nl\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/hollandcapital.nl\/#organization","name":"Holland Capital Management BV","url":"https:\/\/hollandcapital.nl\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/hollandcapital.nl\/#\/schema\/logo\/image\/","url":"https:\/\/hollandcapital.nl\/wp-content\/uploads\/2023\/06\/HC_logo_handtekening.png","contentUrl":"https:\/\/hollandcapital.nl\/wp-content\/uploads\/2023\/06\/HC_logo_handtekening.png","width":186,"height":65,"caption":"Holland Capital Management BV"},"image":{"@id":"https:\/\/hollandcapital.nl\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.linkedin.com\/company\/hollandcapital\/"]},{"@type":"Person","@id":"https:\/\/hollandcapital.nl\/#\/schema\/person\/47531bfba3e92fb43b39366649af58c9","name":"Grytsje","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/287ef07ad6e09cb3368ae7d01a80dfd73cb7a9bb6d5a8f35a2dd4f0c09b95f9a?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/287ef07ad6e09cb3368ae7d01a80dfd73cb7a9bb6d5a8f35a2dd4f0c09b95f9a?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/287ef07ad6e09cb3368ae7d01a80dfd73cb7a9bb6d5a8f35a2dd4f0c09b95f9a?s=96&d=mm&r=g","caption":"Grytsje"},"url":"https:\/\/hollandcapital.nl\/en\/author\/grytsje\/"}]}},"_links":{"self":[{"href":"https:\/\/hollandcapital.nl\/en\/wp-json\/wp\/v2\/posts\/987507945","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/hollandcapital.nl\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/hollandcapital.nl\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/hollandcapital.nl\/en\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/hollandcapital.nl\/en\/wp-json\/wp\/v2\/comments?post=987507945"}],"version-history":[{"count":3,"href":"https:\/\/hollandcapital.nl\/en\/wp-json\/wp\/v2\/posts\/987507945\/revisions"}],"predecessor-version":[{"id":987507949,"href":"https:\/\/hollandcapital.nl\/en\/wp-json\/wp\/v2\/posts\/987507945\/revisions\/987507949"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/hollandcapital.nl\/en\/wp-json\/wp\/v2\/media\/987507937"}],"wp:attachment":[{"href":"https:\/\/hollandcapital.nl\/en\/wp-json\/wp\/v2\/media?parent=987507945"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/hollandcapital.nl\/en\/wp-json\/wp\/v2\/categories?post=987507945"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/hollandcapital.nl\/en\/wp-json\/wp\/v2\/tags?post=987507945"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}